High versus low dose Stereotactic Body Radiation Therapy for hepatic metastases

Doherty, 2006 van der Pool, 2012, Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series, Colorectal Dis, 14, 56, 10.1111/j.1463-1318.2010.02539.x Zaydfudim, 2015, Improving treatment and survival: a population-based study of current outcomes after a hepatic resection in patients with metastatic colorectal cancer, HPB: the official journal of the International Hepato Pancreato Biliary Association, 17, 1019, 10.1111/hpb.12488 Gillams, 2009, Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation, Eur Radiol, 19, 1206, 10.1007/s00330-008-1258-5 Groeschl, 2014, Microwave ablation for hepatic malignancies: a multiinstitutional analysis, Ann Surg, 259, 1195, 10.1097/SLA.0000000000000234 Beermann, 2018, 1000 consecutive ablation sessions in the era of computer assisted image guidance - Lessons learned, Eur J Radiol Open, 6, 1, 10.1016/j.ejro.2018.11.002 Rhim, 2001, Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors, RadioGraphics, 21, S17, 10.1148/radiographics.21.suppl_1.g01oc11s17 Shady, 2016, Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes–a 10-year experience at a single center, Radiology, 278, 601, 10.1148/radiol.2015142489 Gillams, 2015, Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontières meeting 2013, Eur Radiol, 25, 3438, 10.1007/s00330-015-3779-z Lawrence, 1995, Hepatic toxicity resulting from cancer treatment, Int J Radiat Oncol Biol Phys, 31, 1237, 10.1016/0360-3016(94)00418-K Katz, 2007, Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases, Int J Radiat Oncol Biol Phys, 67, 793, 10.1016/j.ijrobp.2006.10.025 Rusthoven, 2009, Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases, J Clin Oncol, 27, 1572, 10.1200/JCO.2008.19.6329 Lee, 2009, Phase I study of individualized stereotactic body radiotherapy of liver metastases, J Clin Oncol, 27, 1585, 10.1200/JCO.2008.20.0600 Rule, 2011, Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases, Ann Surg Oncol, 18, 1081, 10.1245/s10434-010-1405-5 Palma, 2019, Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial, Lancet, 393, 2051, 10.1016/S0140-6736(18)32487-5 Scorsetti, 2013, Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial, Int J Radiat Oncol Biol Phys, 86, 336, 10.1016/j.ijrobp.2012.12.021 Dewas, 2012, Prognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy, Radiat Oncol, 7, 166, 10.1186/1748-717X-7-166 Kruis, 2013, Registration accuracy and image quality of time averaged mid-position CT scans for liver SBRT, Radiother Oncol, 109, 404, 10.1016/j.radonc.2013.08.047 Common terminology criteria for adverse events (CTCAE) v.4.0. [cited 2018 July 2018]; Available from: https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Schemper, 1996, A note on quantifying follow-up in studies of failure time, Control Clin Trials, 17, 343, 10.1016/0197-2456(96)00075-X Wilke, 2019, ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams : Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery, Strahlenther Onkol, 195, 193, 10.1007/s00066-018-1416-x Report 91. Journal of the International Commission on Radiation Units and Measurements, 2017. 14(2): p. 1-160. Andratschke, 2018, The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases, BMC Cancer, 18, 10.1186/s12885-018-4191-2 Scorsetti, 2015, Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer, J Cancer Res Clin Oncol, 141, 543, 10.1007/s00432-014-1833-x Ohri, 2018, Local control after stereotactic body radiation therapy for liver tumors, Int J Radiat Oncol Biol Phys, 10.1016/j.ijrobp.2017.12.288 Klement, 2019, The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases, BMC Cancer, 19, 10.1186/s12885-019-5362-5 Fode, 2015, Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases, Radiother Oncol, 114, 155, 10.1016/j.radonc.2014.12.003 McPartlin, 2017, Long-Term Outcomes of Phase 1 and 2 Studies of SBRT for Hepatic Colorectal Metastases, Int J Radiat Oncol Biol Phys, 99, 388, 10.1016/j.ijrobp.2017.04.010 Joo, 2017, local control outcomes using stereotactic body radiation therapy for liver metastases from colorectal cancer, Int J Radiat Oncol Biol Phys, 99, 876, 10.1016/j.ijrobp.2017.07.030 Jackson, 2018, Comparison of stereotactic body radiation therapy and radiofrequency ablation in the treatment of intrahepatic metastases, Int J Radiation Oncol Biol Phys, 100, 950, 10.1016/j.ijrobp.2017.12.014 Franzese, 2018, Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation, J Cancer Res Clin Oncol, 10.1007/s00432-018-2692-7 Klement, 2017, Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control, Radiother Oncol, 123, 227, 10.1016/j.radonc.2017.01.013